BioKinetic Europe has successfully completed studies for many international companies, covering a wide range of therapeutic areas – early Phase I and Proof of Concept are specific areas of expertise.
With experience in over 400 clinical trials for global sponsor companies in Europe, North America and Asia, across a wide range of therapeutic areas, we work collaboratively with your clinical research teams to design a programme of early phase studies best suited to your drugs’ needs. Our accreditations, alongside an impeccable track record, are supported by a wealth of experience in phase one to three clinical projects.
With BioKinetic, you are assured your trial is in safe hands.
BioKinetic has held Medicines and Healthcare products Regulatory Agency (MHRA) Supplementary Accreditation since 2009. This is the only such accreditation scheme in Europe and enables us to carry out NCE / First-in-Man clinical trials with associated medical emergency procedures. This accreditation is a clear symbol of the high quality of service provided by our team.
The Phase I Accreditation Scheme, which was introduced in 2006, is designed to promote “best practice” procedures encompassing the highest standards for avoiding harm to trial participants and for handling medical emergencies. The UK’s favourable regulatory environment, its openness to adaptive trial designs and stringent clinical trial application process continues to affirm the region’s status as a world leader in clinical research and the preferred location for early phase clinical trials.
BioKinetic Europe are again thrilled to have been shortlisted for the Business Growth award in the Belfast Business Awards 2016, organised by Belfast Chamber of Trade and Commerce.This category recognised those businesses who have shown substantial growth in a difficult period of trading and have introduced new products or services to positively impact the business.
We were shortlisted alongside a high calibre collection of companies within the Pharma industry in Ireland. This award is a real testament to the skill, hard work and dedication of our staff over the last year which has been an exceptional (and it seems continuing!) time of growth for us. As well as being awarded Pharma Contract Services Company of the Year, we were also finalists in the Pharma Industry Company of the Year award.
BioKinetic were finalists in the Research and Development Achievement Award in the 2014 all-Ireland Pharma Industry Awards. This award recognises individuals or teams working in the pharmaceutical sector for research and commercial development of new products and/or new processes for making useful products.
BioKinetic was awarded Best Small / Medium Business at the 2014 Belfast Telegraph Business Awards.These awards are regarded as the premier symbol of commercial, industrial and social enterprise achievements in Northern Ireland. This category was the most highly contested category with a record number of entries competing for the title. This award is fair recognition for the hard work and dedication of our staff over the last year which has been a time of exceptional growth for us.
Investors in People is a business improvement tool designed to help businesses of all sizes and sectors develop performance through their people. It provides tailored assessments which are designed to support organisations in planning, implementing and evaluating effective strategies. The distinctive and iconic Investors in People laurel has become a symbol of a responsible organisation and best practice in people management. BioKinetic Europe sees their continued partnership with Investors in People, spanning more than a decade, as a clear indication of the organisation’s ever increasing investment into staff.
Feasibility & Study Award
Database lock, review of CSR, study close-out